Citadel Advisors
ASTH icon

Citadel Advisors’s Astrana Health ASTH Stock Holding History

Citadel Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$613K Sell
25,019
-6,485
-21% -$154K ﹤0.01% 8791
2025
Q4 		$782K Sell
31,504
-21,014
-40% -$558K ﹤0.01% 7964
2025
Q3 		$1.49M Sell
52,518
-131,372
-71% -$3.56M ﹤0.01% 6693
2025
Q2 		$4.58M Sell
183,890
-96,409
-34% -$2.72M ﹤0.01% 4270
2025
Q1 		$8.69M Buy
+280,299
New +$9.34M ﹤0.01% 3042
2024
Q3 		– Sell
-22,181
Closed -$1.09M – 15415
2024
Q2 		$900K Sell
22,181
-22,437
-50% -$890K ﹤0.01% 6802
2024
Q1 		$1.87M Sell
44,618
-57,425
-56% -$2.24M ﹤0.01% 5656
2023
Q4 		$3.91M Sell
102,043
-72,763
-42% -$2.42M ﹤0.01% 4162
2023
Q3 		$5.39M Buy
174,806
+34,966
+25% +$1.21M ﹤0.01% 3536
2023
Q2 		$4.42M Sell
139,840
-2,668
-2% -$91.5K ﹤0.01% 3837
2023
Q1 		$5.2M Sell
142,508
-63,598
-31% -$2.23M ﹤0.01% 3742
2022
Q4 		$6.1M Sell
206,106
-57,059
-22% -$1.83M ﹤0.01% 3542
2022
Q3 		$10.3M Buy
+263,165
New +$12M ﹤0.01% 2718
2022
Q2 		– Sell
-14,360
Closed -$546K – 14287
2022
Q1 		$696K Sell
14,360
-49,388
-77% -$2.55M ﹤0.01% 8585
2021
Q4 		$4.68M Buy
63,748
+59,818
+1,522% +$4.91M ﹤0.01% 4414
2021
Q3 		$358K Buy
+3,930
New +$334K ﹤0.01% 10672
2021
Q2 		– Sell
-68,558
Closed -$1.86M – 14563
2021
Q1 		$1.86M Buy
+68,558
New +$1.65M ﹤0.01% 6563
2020
Q4 		– Sell
-25,892
Closed -$465K – 11626
2020
Q3 		$465K Buy
25,892
+10,106
+64% +$174K ﹤0.01% 7428
2020
Q2 		$261K Buy
15,786
+3,610
+30% +$56.8K ﹤0.01% 8136
2020
Q1 		$157K Buy
+12,176
New +$199K ﹤0.01% 8254
2019
Q4 		– Sell
-16,970
Closed -$299K – 9873
2019
Q3 		$299K Buy
+16,970
New +$290K ﹤0.01% 7557
2018
Q4 		– Sell
-24,175
Closed -$534K – 9862
2018
Q3 		$534K Buy
+24,175
New +$509K ﹤0.01% 6589

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors's ASTH Position: Q1 2026 in Review

Citadel Advisors reduced its Astrana Health (ASTH) stake by 21% in Q1 2026, selling an estimated $154K and leaving 25,019 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #8791.

Citadel Advisors first reported a position in ASTH in Q3 2018 and has held it in 22 quarters since. The position peaked at $10.3M in Q3 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Citadel Advisors held 25,019 shares of Astrana Health worth $613K as of Q1 2026.
  • Citadel Advisors sold 6,485 Astrana Health shares in Q1 2026, an estimated $154K.
  • Astrana Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8791 holding.
  • Citadel Advisors first reported a position in Astrana Health in Q3 2018 and has held it in 22 quarters since.
  • Citadel Advisors's Astrana Health position peaked at $10.3M in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.